Hims & Hers Health Inc. (NYSE:HIMS) shares are trading higher Thursday. The stock appears to be bouncing back a bit after selling off to start the week. Here’s a look at what you need to know.
What To Know: Novo Nordisk on Monday terminated its collaboration with the telehealth company, accusing it of violating drug compounding laws and marketing practices related to semaglutide, the active ingredient in Wegovy.
